Anti-AKT2 antibody
Catalog No : FT-FNab00272
302.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Description | AKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis and their activation has been observed in a wide variety of cancers. AKT2 is mainly involved in cancer cell survival, apoptosis inhibition, migration and invasion(PMID:21979951). The full length protein has four glycosylation sites. | ||
|---|---|---|---|
| Other names | |||
| Cellular localization | |||
| Research area | Metabolism, Cardiovascular, Immunology, Developmental biology, Neuroscience | ||
| Note | This product is for research purpose only, not for use in diagnostics or as therapeutics. | ||
| Uniprot ID | P31751 | ||
| Product name | Anti-AKT2 antibody | ||
|---|---|---|---|
| Catalog No | FT-FNab00272 | ||
| Supplier’s Catalog No | FNab00272 | ||
| Supplier | Fine Test (Wuhan Fine Biotech) | ||
| Host species | Rabbit | ||
| Species reactivity | Human, Mouse, Rat | ||
| Applications | ELISA, WB, IHC, IP | ||
| Recommended dilutions | WB: 1:500-1:2000, IP: 1:200-1:2000, IHC: 1:20-1:200 | ||
| Molecular weight | 55 kDa | ||
| Conjugate | Unconjugated | ||
| Immunogen | v-akt murine thymoma viral oncogene homolog 2 | ||
| Specificity | N/A | ||
| Storage | Store at -20°C. Avoid repeated freeze and thaw cycles. | ||
|---|---|---|---|
| Clonality | Polyclonal | ||
| Isotype | IgG | ||
| Clone ID | N/A | ||
| Concentration | 1 mg/mL | ||
| Storage buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3 | ||
| Formulation | Liquid | ||
| Purification | Immunogen affinity purified, ≥95% as determined by SDS-PAGE | ||
| Handling | This product contains NaN3 as preservative, please take appropriate care when handling this product. | ||
| Reactivity life | 12 months when stored properly according to instructions. | ||
Product Details
© 2020 Imugex All Rights Reserved